AF
BDSX icon

Amalgamated Financial’s Biodesix BDSX Stock Holding History

Amalgamated Financial’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$4K Buy
+105
New +$6.86K ﹤0.01% 2968

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Amalgamated Financial's BDSX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Biodesix (BDSX) in Q1 2022: 105 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #2968 among its holdings.

46 funds tracked by Wall St. Rank hold BDSX as of Q1 2022.

  • Amalgamated Financial held 105 shares of Biodesix worth $4K as of Q1 2022.
  • Biodesix was a new Amalgamated Financial position in Q1 2022.
  • Biodesix made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2968 holding.
  • 46 funds tracked by Wall St. Rank held Biodesix as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.